Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Men only

Oxiblume:CoQ10 Therapy for Chronic Prostatitis and Pelvic Pain

Official title: Oxiblume:CoQ10 (Ralivia) Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): a Double-blind Placebo-controlled Randomized Clinical Trial Assessing Treatment Efficacy and Safety.

Run by G.Gennimatas General Hospital · NCT07629505 · Data updated 2026-11-12

A double-blind, placebo-controlled test to see if Oxiblume:CoQ10 helps people aged 18–50 with Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

More Chronic Pelvic Pain Syndrome (CPPS) trials

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexMen only
Enrollment100 (estimated)
SponsorG.Gennimatas General Hospital
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Thessaloniki)
StatusRecruiting
StartedJune 8, 2026
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 5, 2026
Trial IDNCT07629505 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–50 with a clinical CP/CPPS diagnosis and pain for at least three months within the last six months.

Probably not a fit

Patients with certain urinary infections, prior urological cancers, prior pelvic treatments, or other conditions in the exclusion list may not benefit and could be unlikely to respond.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests the efficacy and safety of Oxiblume:CoQ10 (Ralivia) versus placebo in adults with CP/CPPS. It is a randomized, double-blind, placebo-controlled design to minimize bias and assess symptom relief and tolerability. Participants must have at least three months of pelvic or perineal pain within the past six months and meet specific health criteria. The study is coordinated by the Research Office of the 1st Urology Department at G. Gennimatas General Hospital in Thessaloniki. Outcome measures and detailed methods are not fully provided here, but the design follows standard phytotherapy approaches with emphasis on safety and repeatability of treatment cycles.

Why it matters

Potential benefit: If successful, patients may experience reduced pelvic pain and improved quality of life with a therapy that is cost-effective and potentially repeatable.

How similar studies have gone: Phytotherapy approaches have shown promise in CP/CPPS, but results are variable and prior studies have limitations; this trial adds a rigorous randomized design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participant must be between 18 and 50 years old.
2. Participant has signed and dated the appropriate Informed Consent document.
3. Participant has had a clinical diagnosis of CP/CPPS defined as symptoms of discomfort or pain in the perineal or pelvic region for at least a three (3) month period within the last six (6) months.

Exclusion Criteria:

1. Participant has evidence of facultative Gram negative or enterococcus with a value of ≥ 1000 CFU/ml in mid-stream urine (VB2).
2. Participant has a history of prostate, bladder or urethral cancer.
3. Participant has undergone pelvic radiation or systemic chemotherapy.
4. Participant has undergone intravesical chemotherapy.
5. Participant has unilateral orchialgia without pelvic symptoms, active urethral stricture or bladder stones, or any other urological condition associated with LUTS, any neurological disease or disorder affecting the bladder.
6. Participant has undergone prostate surgery or treatment.
7. Participant with penile or urinary sphincter implants.
8. Participant has been diagnosed with cancer during the last 5 years or had any surgery in the pelvis.
9. Participant has a neurological impairment or psychiatric disorder preventing his understanding of consent and his ability to comply with the protocol.

Where it's running

  • G.Gennimatas General Hospital
    Thessaloniki, Greece
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.